Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
Douillard
Jean-Yves
JY
Centre René Gauducheau, Nantes, France. jy-douillard@nantes.fnclcc.fr
Siena
Salvatore
S
Cassidy
James
J
Tabernero
Josep
J
Burkes
Ronald
R
Barugel
Mario
M
Humblet
Yves
Y
Bodoky
György
G
Cunningham
David
D
Jassem
Jacek
J
Rivera
Fernando
F
Kocákova
Ilona
I
Ruff
Paul
P
Błasińska-Morawiec
Maria
M
Šmakal
Martin
M
Canon
Jean-Luc
JL
Rother
Mark
M
Oliner
Kelly S
KS
Wolf
Michael
M
Gansert
Jennifer
J